Stay updated with breaking news from Alimera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ATLANTA, Aug. 10, 2022 -- Alimera Sciences, Inc. , a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and... | August 10, 2022
/PRNewswire/ -- The Uveitis Drugs Market report has been added to Technavio's offering. With ISO 9001:2015 certification, Technavio is proudly partnering with...
Alimera Sciences, Inc. (NASDAQ:NASDAQ:ALIM) Q2 2022 Earnings Conference Call July 27, 2022 09:00 AM ET Company Participants Scott Gordon - CORE, Investor Relations Rick Eiswirth - President...
Analysts at Future Market Insights find that the global Implantable Drug Eluting Devices Market during the historic period 2014-2018. The market study suggests that the global market size of Implantable Drug-Eluting Devices is projected to reach ~US$ 10.7 Bn by the end of 2022 with a CAGR of 6% over the stipulated t...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.